Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Regulatory News
 
CFDA Seeks Public Comments on Health Food Filing Rules 2/7/2017
CFDA Issues Announcement over General Considerations for Clinical... 2/7/2017
CFDA Solicits Comments on Rules for Licensing Evaluation of Speci... 1/25/2017
The State Council Withdraws Three Local Pharma Approval Requireme... 1/23/2017
CFDA Issues the General Considerations for Drug Clinical Trials 1/20/2017
CFDA Issues Announcement for Standard Code Data under National Dr... 1/20/2017
CFDA Launches National Online Database for Substandard Drugs 1/15/2017
CFDA Holds National Food and Drug Regulatory Conference, Outlinin... 1/13/2017
CFDI to Initiate Clinical Data Inspection of 31 Drug Products 1/13/2017
NHFPC Establishes Expert Committee for Antibiotic Application and... 1/12/2017
CFDA Withdraws Approvals of 147 Drug Products 1/11/2017
CFDA Solicits Public Comments on Naming Principle of Formulated T... 1/11/2017
U.S. DEA Opens China Office to Help Fight Synthetic Drug Trade (free) 1/10/2017
Data Snapshot - Review of Chinese Drug Registration Applications ... 1/10/2017
CDE Seeks Public Comments on Proposed Guideline for Chemical Drug... 1/10/2017
CFDA Announces Overview of Drug Applications under MAH Trial 1/6/2017
CFDA Announces Latest Clinical Data Inspection Plan 1/4/2017
CFDA Offer Interpretations on the Ongoing MAH Trial 1/4/2017
CDE Solicits Comments on Guidelines for Compatibility Research of... 12/30/2016
CFDA Announces Revisions to the Five Appendices of GSP 12/29/2016
CFDA Solicits Comments on Decision to Change Certain Drug Evaluat... 12/29/2016
CFDA Solicits Comments on Rules for Confidentiality in Review of ... 12/29/2016
CDE Solicits Comments on Production Process Registration of Marke... 12/26/2016
China Approves TCM Law with Effect in July 2017 12/26/2016
CFDA Drafts Four Guidelines for Onsite Inspection of Generic Drug... 12/22/2016
China Eyes Introduction of "Orange Book" 12/19/2016
Six Central Chinese Cities Join Hands to Fight Dishonesty of Food... 12/19/2016
Drug Registration Approval and Application Update 11/2016 12/19/2016
CDE Solicits Comments on Draft Guideline for Research and Review ... 12/16/2016
CFDA Issues Revision of Guideline for GSP Onsite Inspections 12/16/2016
Page:4/7    Total number of articles:196  :[1][2][3][4][5][>>][End]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links